Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

COVID-19 & Inpatient Continuous Glucose Monitoring: A New Opportunity?

COVID-19 & Inpatient Continuous Glucose Monitoring: A New Opportunity? C VID-19 Inpatient Continuous Glucose Monitoring A New Opportunity? SALLY O. GERARD, DNP, RN, CDCES LAURIEANN SCHER, MS, RD, CDCES The value of continuous glucose monitoring to limit provider contact. Whereas nationally some (CGM) as a tool for managing blood glucose, organizations expanded CGM use, the technology preventing diabetes-related complications, and was ultimately not adapted for expanded use optimizing treatment options is well established. at Stamford Hospital. Despite this choice, the The technology has been used in the outpatient pandemic highlighted the potential value of setting by people with diabetes (PWD) and their greater CGM utilization in inpatient settings and practitioners to assist with direct clinical decision- the need for proper planning, education, and making and self-management. In recent years, research to allow CGM to become a valuable CGM technology has grown from a somewhat inpatient tool for glycemic care in the future. specific group of users to a wider consumer CGM Inpatient Use Before COVID-19 market. As the increase in CGM use has increased, The burden of care from year to year, day to day, so has its presence in the inpatient setting when or hour to hour can be significant for PWD. CGM CGM users are admitted http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png ADCES in Practice SAGE

COVID-19 & Inpatient Continuous Glucose Monitoring: A New Opportunity?

Gerard, Sally O.; Scher, LaurieAnn
ADCES in Practice , Volume 9 (2): 7 – Mar 1, 2021
Download PDF
7 pages

Loading next page...
 
/lp/sage/covid-19-inpatient-continuous-glucose-monitoring-a-new-opportunity-TCfyB0S408

References (6)

Publisher
SAGE
Copyright
© 2021 by the American Association of Diabetes Educators
ISSN
2633-559X
eISSN
2633-5603
DOI
10.1177/2633559X20985474
Publisher site
See Article on Publisher Site

Abstract

C VID-19 Inpatient Continuous Glucose Monitoring A New Opportunity? SALLY O. GERARD, DNP, RN, CDCES LAURIEANN SCHER, MS, RD, CDCES The value of continuous glucose monitoring to limit provider contact. Whereas nationally some (CGM) as a tool for managing blood glucose, organizations expanded CGM use, the technology preventing diabetes-related complications, and was ultimately not adapted for expanded use optimizing treatment options is well established. at Stamford Hospital. Despite this choice, the The technology has been used in the outpatient pandemic highlighted the potential value of setting by people with diabetes (PWD) and their greater CGM utilization in inpatient settings and practitioners to assist with direct clinical decision- the need for proper planning, education, and making and self-management. In recent years, research to allow CGM to become a valuable CGM technology has grown from a somewhat inpatient tool for glycemic care in the future. specific group of users to a wider consumer CGM Inpatient Use Before COVID-19 market. As the increase in CGM use has increased, The burden of care from year to year, day to day, so has its presence in the inpatient setting when or hour to hour can be significant for PWD. CGM CGM users are admitted

Journal

ADCES in Practice – SAGE

Published: Mar 1, 2021

There are no references for this article.